List: NSW schools, unis targeted in massive global cyber attack Daily Telegraph Sydney
StockWatch: enGene Shares Crater on Declines in Complete Response Rates to Bladder Cancer Therapy
enGene (NASDAQ: ENGN) stock suffered an 83% plunge this past week that reflects just how competitive the field is among drug candidates for nonmuscle invasive


